BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36485067)

  • 1. Assessment of prognostic and reproductive outcomes of omentectomy for patients with clinically apparent early-stage (I, II) malignant ovarian germ cell tumours: A multicentre retrospective study.
    Liu P; Li Z; Cheng X; Gao Q; Che Y; Zhang Z; Chu R; Chen Z; Zhang Y; Wang Q; Dou Z; Wei Y; Cui Z; Wang J; Xie X; Ma D; Yang X; Kong B; Song K
    BJOG; 2022 Nov; 129 Suppl 2():23-31. PubMed ID: 36485067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases.
    Xu W; Li Y
    Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of staging surgery in the treatment of apparent early-stage malignant ovarian germ cell tumours.
    Zhao T; Zhang H; Liu Y; Jiang H; Wang X; Lu Y
    Aust N Z J Obstet Gynaecol; 2016 Aug; 56(4):398-402. PubMed ID: 27135780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center.
    Mikuš M; Benco N; Matak L; Planinić P; Ćorić M; Lovrić H; Radošević V; Puževski T; Bajt M; Vujić G
    Arch Gynecol Obstet; 2020 May; 301(5):1227-1233. PubMed ID: 32253553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALIGNANT OVARIAN GERM CELL TUMORS AT A TERTIARY CARE SETTING IN PAKISTAN.
    Hannan A; Malik MA; Fasih S; Badar F; Siddiqui N
    J Ayub Med Coll Abbottabad; 2015; 27(3):624-7. PubMed ID: 26721024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
    Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
    Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multicenter randomized controlled clinical study for the operative treatment of malignant ovarian germ cell tumors].
    Liu Q; Ding XL; Yang JX; Cao DY; Shen K; Lang JH; Zhang GN; Xin XY; Xie X; Zhang SL; Wu YM; Zhu GH; Wang J; Chen YL; Kong BH; Zheng JH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):188-92. PubMed ID: 23849941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution.
    Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C
    Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of malignant ovarian germ cell tumors and preservation of fertility.
    Zhang R; Sun YC; Zhang GY; Wu LY; Zuo J
    Eur J Gynaecol Oncol; 2012; 33(5):489-92. PubMed ID: 23185794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumors.
    Qin B; Xu W; Li Y
    Jpn J Clin Oncol; 2020 Mar; 50(3):282-287. PubMed ID: 31867612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
    Yang ZJ; Wei RJ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
    Yang ZJ; Liu ZC; Wei RJ; Li L
    Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 8-year analysis of the prevalence of lymph nodes metastasis, oncologic and pregnancy outcomes in apparent early-stage malignant ovarian germ cell tumors.
    Chatchotikawong U; Ruengkhachorn I; Leelaphatanadit C; Phithakwatchara N
    Asian Pac J Cancer Prev; 2015; 16(4):1609-13. PubMed ID: 25743840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Jun; 145(3):513-518. PubMed ID: 28372870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2016 Jun; 26(5):859-64. PubMed ID: 27101582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management and outcomes for stage 1 malignant ovarian germ cell tumours: A UK multicentre retrospective cohort study.
    Graham R; MacDonald ND; Lockley M; Miller R; Butler J; Murali K; Sarker SJ; Banerjee S; Stoneham S; Shamash J; Liberale V; Berney DM; Newton C
    Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():138-144. PubMed ID: 35192975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.
    Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F
    J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report.
    Ghalleb M; Bouzaiene H; Slim S; Hadiji A; Hechiche M; Ben Hassouna J; Rahal K
    J Med Case Rep; 2017 Dec; 11(1):350. PubMed ID: 29248013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
    Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
    Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germinal ovarian tumors in reproductive age women: Fertility-sparing and outcome.
    Dellino M; Silvestris E; Loizzi V; Paradiso A; Loiacono R; Minoia C; Daniele A; Cormio G
    Medicine (Baltimore); 2020 Sep; 99(39):e22146. PubMed ID: 32991408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.